Wells Fargo & Company Issues Positive Forecast for Omega Healthcare Investors (NYSE:OHI) Stock Price

Omega Healthcare Investors (NYSE:OHI) had its target price lifted by Wells Fargo & Company from $41.00 to $44.00 in a research report report published on Wednesday morning,Benzinga reports. The brokerage currently has an overweight rating on the real estate investment trust’s stock.

Separately, Royal Bank Of Canada raised their price objective on shares of Omega Healthcare Investors from $39.00 to $41.00 and gave the stock a “sector perform” rating in a research report on Thursday, August 7th. Four investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Omega Healthcare Investors currently has an average rating of “Moderate Buy” and an average price target of $42.86.

Omega Healthcare Investors Trading Up 1.6%

OHI opened at $42.66 on Wednesday. The company has a quick ratio of 7.10, a current ratio of 7.10 and a debt-to-equity ratio of 0.96. Omega Healthcare Investors has a 52 week low of $35.04 and a 52 week high of $44.42. The business’s 50 day moving average is $38.84 and its two-hundred day moving average is $37.70. The firm has a market cap of $12.59 billion, a price-to-earnings ratio of 26.34, a price-to-earnings-growth ratio of 2.23 and a beta of 0.66.

Omega Healthcare Investors (NYSE:OHI) last announced its earnings results on Thursday, July 31st. The real estate investment trust reported $0.77 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.45 by $0.32. The business had revenue of $235.60 million for the quarter, compared to analyst estimates of $248.49 million. Omega Healthcare Investors had a net margin of 42.23% and a return on equity of 9.78%. The company’s revenue for the quarter was up 11.8% compared to the same quarter last year. During the same period last year, the firm posted $0.71 earnings per share. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. On average, research analysts predict that Omega Healthcare Investors will post 2.86 EPS for the current year.

Omega Healthcare Investors Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Monday, August 4th were paid a dividend of $0.67 per share. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.3%. The ex-dividend date was Monday, August 4th. Omega Healthcare Investors’s payout ratio is 165.43%.

Insider Transactions at Omega Healthcare Investors

In related news, Director Lisa Egbuonu-Davis sold 2,500 shares of the firm’s stock in a transaction dated Friday, August 8th. The shares were sold at an average price of $40.16, for a total value of $100,400.00. Following the completion of the sale, the director owned 18,654 shares in the company, valued at $749,144.64. This trade represents a 11.82% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.50% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Omega Healthcare Investors

A number of large investors have recently modified their holdings of the business. Caitong International Asset Management Co. Ltd purchased a new stake in shares of Omega Healthcare Investors in the second quarter valued at approximately $26,000. NBC Securities Inc. acquired a new stake in Omega Healthcare Investors in the first quarter valued at $29,000. Smartleaf Asset Management LLC lifted its holdings in Omega Healthcare Investors by 40.9% in the second quarter. Smartleaf Asset Management LLC now owns 924 shares of the real estate investment trust’s stock valued at $34,000 after acquiring an additional 268 shares during the period. CENTRAL TRUST Co boosted its position in shares of Omega Healthcare Investors by 1,654.4% during the 2nd quarter. CENTRAL TRUST Co now owns 1,000 shares of the real estate investment trust’s stock worth $37,000 after purchasing an additional 943 shares in the last quarter. Finally, Bayforest Capital Ltd grew its stake in shares of Omega Healthcare Investors by 395.2% during the 2nd quarter. Bayforest Capital Ltd now owns 1,129 shares of the real estate investment trust’s stock worth $41,000 after purchasing an additional 901 shares during the period. 65.25% of the stock is owned by hedge funds and other institutional investors.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.